January, 2005:
- Fosamax patent ruling another blow for Merck
- Greenfield Online acquires Rapidata.net
- British Medical Journal retracts Prozac report
- Cialis set for Super Bowl return
- AstraZeneca expects earnings rise despite Crestor, Exanta, Iressa questions
- MS&L opens Quebec office and names SVP
- Two Industry Veterans Launch JYT Health
- Pharma companies increase prices on popular drugs
- Johnson & Johnson sees global pharmaceutical sales jump
- Mindspan adds Jim King as VP, business development
- Final Medicare Rx benefit rules unveiled
- ISN and NPG partner to create new journal
- FDA approves 31 NMEs in 2004, 10 more than in 2003
- Mobic’s blockbuster potential follows COX-2 bad news
- Novartis to air eye Rx ad during first half of Super Bowl
- MediaVest transfer prompted by assignment concentration
- Ortho-McNeil seeks NDA for premature ejaculation drug
- Pfizer purchases Angiosyn, deal to close in first quarter
- Former Aventis executives now in new Novo Nordisk posts
- Chandler Chicco acquires Korea communications firm
- Bristol-Myers Squibb, Ventiv ink multi-year service deal
- Ogilvy and Healthworld merge to form new agency
- Journal study raises questions about Plavix
- Prounis launches new agency
- Competitive market should keep drug prices down, HHS nominee says
- CommonHealth launches new agency
- Drug Store News, NACDS to host Rx marketing event for seniors
- FDA to again decide on OTC switch for Plan B contraceptive
- Schering-Plough makes changes in its R&D operations
- FDA panel rejects OTC request for Mevacor
- J&J's Christine Poon accepts additional roles
- FDA panel considers nonprescription sale of Mevacor
- Palio makes several promotions
- FDA issues warning over Celebrex, Bextra ads
- Chandler Chicco Agency acquires Ignition Strategic Communications
- Stonefly adds five to its staff
- Big pharma launches new discount card
- Prescription drug spending slows
- AstraZeneca’s Crestor linked to a death
- Publicis Selling Solutions launches first CSO sales force
- Par taps MacPhee as new SVP, branded marketing and sales
- Legal challenge to Lipitor worries Wall Street
- Novartis taps Euro for Elidel, Lamisil med ed
- Bayer buys rights to market Levitra abroad
- New form of Taxol approved.
- Sudler & Hennessey acquires Current Medical Directions
- Consumer health exposition to focus on family caregivers
- Redi-Mail acquires PPS Medical Marketing Group
- People, Product and Agency News from the Jan. 7th MM&M News Brief
- Torre Lazur McCann names Ouimette as president
- Schering-Plough names Omnicom, Publicis to handle Rx ads
- AZ cuts 500 contract sales jobs
- Drug companies urged to improve R&D strategies
- Andrx abandons brand-name drug business
- USP issues final Medicare drug benefit plan
- Seasonale warned by FDA for ads
- McCarthy promoted at Lanmark Group
- Setback for Pfizer drug Lyrica
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.
MMM Articles
- Poll shows all ages seek digital health tools
- Survey shows docs overestimate adherence
- Drugmaker shifts sales model to keep pace with formulary decision making
- Oncologist's petition is latest salvo, as drug-pricing issue rises to new prominence
- Global cancer drug market to grow to $111 billion by 2020: report
